Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Generation Bio Co. GBIO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
39/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Generation Bio Co. (GBIO) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 5 Buy, 5 Hold.

GBIO Analyst Ratings

Buy
10
Ratings
5 Buy
5 Hold
Based on 10 analysts giving stock ratings to Generation Bio Co. in the past 3 months
Rating breakdown
Buy
5 50%
Hold
5 50%
50%
Buy
5 analysts
50%
Hold
5 analysts
0%
Sell
0 analysts

People Also View

ERAS
ERAS
Erasca, Inc.
$17.85
+9.44%
 EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
 STOK
STOK
Stoke Therapeutics, Inc.
$35.86
+2.31%
 NUVB
NUVB
Nuvation Bio Inc.
$4.85
+3.19%
 GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$17.50
-0.28%
 SANA
SANA
Sana Biotechnology, Inc.
$3.48
+8.41%
 LYEL
LYEL
Lyell Immunopharma, Inc.
$23.37
-5.77%
 STTK
STTK
Shattuck Labs, Inc.
$6.78
+0.15%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message